What drove the SKIN.SW stock move today?

SKIN.SW stock rose **9.85%** on **05 Mar 2026** with volume **2,756.00**, above average. No earnings were scheduled, so intraday flows and biotech-specific interest likely caused the move.

What is Meyka AI's price target for SKIN.SW stock?

Meyka AI's forecast model projects **CHF42.00**, implying an upside of **17.65%** versus the close at **CHF35.70**. This is a model projection and not a guarantee.

Is SKIN.SW stock a buy after today’s spike?

Meyka AI assigns SKIN.SW a **B (HOLD)** grade. Given negative EPS **CHF-1.27**, high PB **26.22**, and modest liquidity, we recommend waiting for confirmed catalysts or sustained volume.

Where can I find official company information for SKIN.SW?

Official filings and product information are available on Cassiopea’s website at [Cassiopea](https://www.cassiopea.com). Use those sources for regulatory updates and trial results.

CH Stocks

SKIN.SW Cassiopea S.p.A. (SIX) jumps 9.85% on high volume 05 Mar 2026: Monitor 50-day trend

ByHuzaifa Zahoor March 6, 2026March 6, 2026

SKIN.SW stock rose 9.85% to CHF35.70 at market close on 05 Mar 2026, making it one of today’s high volume movers on the SIX exchange in Switzerland. Volume finished at 2,756.00 versus an average of 1,818.00, a 1.52x pickup that helped lift the price from an open of CHF32.00 to a day high of CHF36.00. There is no scheduled earnings announcement today, so the move appears driven by intraday flows and clinical or sector chatter rather than a company release. We contextualise the jump, valuation, technicals and risk for investors watching SKIN.SW stock.